Jefferies Reconfirms Perrigo Company plc (NYSE:PRGO) As a Hold; They Now Have a Target Price Of $71.0

January 16, 2018 - By Migdalia James

 Jefferies Reconfirms Perrigo Company plc (NYSE:PRGO) As a Hold; They Now Have a Target Price Of $71.0

Investors sentiment decreased to 0.79 in Q3 2017. Its down 0.09, from 0.88 in 2017Q2. It worsened, as 42 investors sold Perrigo Company plc shares while 143 reduced holdings. 57 funds opened positions while 89 raised stakes. 112.10 million shares or 2.05% less from 114.45 million shares in 2017Q2 were reported.

Livforsakringsbolaget Skandia Omsesidigt invested 0.04% in Perrigo Company plc (NYSE:PRGO). Middleton & Inc Ma holds 0.05% of its portfolio in Perrigo Company plc (NYSE:PRGO) for 2,950 shares. Clearbridge Limited Com owns 76 shares. Caisse De Depot Et Placement Du Quebec holds 0% in Perrigo Company plc (NYSE:PRGO) or 18,221 shares. Voloridge Mngmt Limited Liability reported 19,570 shares stake. Cap Rech Glob Invsts invested in 3.07M shares. 388,293 were accumulated by Ubs Asset Mngmt Americas Inc. Illinois-based Magnetar Financial Limited has invested 0.01% in Perrigo Company plc (NYSE:PRGO). Vident Advisory Limited stated it has 18,454 shares or 0.08% of all its holdings. Spirit Of America Ny stated it has 0.01% of its portfolio in Perrigo Company plc (NYSE:PRGO). Virtus Inv Advisers stated it has 0.01% in Perrigo Company plc (NYSE:PRGO). Quinn Opportunity Prns Lc invested in 0.17% or 13,080 shares. 3,256 are held by First Republic Management Inc. Mutual Of America Management Ltd Limited Liability Company holds 0.02% or 14,938 shares. Nj State Employees Deferred Compensation Plan has invested 0.05% in Perrigo Company plc (NYSE:PRGO).

Perrigo Company plc (NYSE:PRGO) Rating Reaffirmed

In a research report revealed to investors on Friday morning, The Hold rating of Perrigo Company plc (NYSE:PRGO) shares was reaffirmed by Analysts at Jefferies, who now has a $71.0 price target on the stock. Jefferies’s price target would indicate a possible downside of -22.66 % from the last stock close price of the company.

Investors sentiment decreased to 0.79 in Q3 2017. Its down 0.09, from 0.88 in 2017Q2. It worsened, as 42 investors sold Perrigo Company plc shares while 143 reduced holdings. 57 funds opened positions while 89 raised stakes. 112.10 million shares or 2.05% less from 114.45 million shares in 2017Q2 were reported.

Livforsakringsbolaget Skandia Omsesidigt invested 0.04% in Perrigo Company plc (NYSE:PRGO). Middleton & Inc Ma holds 0.05% of its portfolio in Perrigo Company plc (NYSE:PRGO) for 2,950 shares. Clearbridge Limited Com owns 76 shares. Caisse De Depot Et Placement Du Quebec holds 0% in Perrigo Company plc (NYSE:PRGO) or 18,221 shares. Voloridge Mngmt Limited Liability reported 19,570 shares stake. Cap Rech Glob Invsts invested in 3.07M shares. 388,293 were accumulated by Ubs Asset Mngmt Americas Inc. Illinois-based Magnetar Financial Limited has invested 0.01% in Perrigo Company plc (NYSE:PRGO). Vident Advisory Limited stated it has 18,454 shares or 0.08% of all its holdings. Spirit Of America Ny stated it has 0.01% of its portfolio in Perrigo Company plc (NYSE:PRGO). Virtus Inv Advisers stated it has 0.01% in Perrigo Company plc (NYSE:PRGO). Quinn Opportunity Prns Lc invested in 0.17% or 13,080 shares. 3,256 are held by First Republic Management Inc. Mutual Of America Management Ltd Limited Liability Company holds 0.02% or 14,938 shares. Nj State Employees Deferred Compensation Plan has invested 0.05% in Perrigo Company plc (NYSE:PRGO).

Perrigo Company plc (NYSE:PRGO) Ratings Coverage

Among 19 analysts covering Perrigo Company Plc (NYSE:PRGO), 8 have Buy rating, 0 Sell and 11 Hold. Therefore 42% are positive. Perrigo Company Plc has $241 highest and $6000 lowest target. $101.06’s average target is 10.09% above currents $91.8 stock price. Perrigo Company Plc had 71 analyst reports since October 23, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained it with “Buy” rating and $8500 target in Monday, July 24 report. On Tuesday, December 22 the stock rating was initiated by Northland Capital with “Outperform”. The firm has “Neutral” rating by JP Morgan given on Tuesday, April 26. RBC Capital Markets maintained it with “Sell” rating and $6000 target in Friday, July 14 report. The rating was maintained by Barclays Capital with “Overweight” on Tuesday, April 26. The firm has “Buy” rating given on Wednesday, November 18 by B. Riley & Co. The stock has “Buy” rating by Argus Research on Friday, December 8. RBC Capital Markets downgraded the stock to “Underperform” rating in Monday, June 5 report. On Friday, October 27 the stock rating was maintained by Jefferies with “Hold”. The firm has “Hold” rating by Jefferies given on Thursday, November 9.

The stock decreased 0.21% or $0.19 during the last trading session, reaching $91.8. About 559,679 shares traded. Perrigo Company plc (NYSE:PRGO) has declined 23.00% since January 16, 2017 and is downtrending. It has underperformed by 39.70% the S&P500.

Analysts await Perrigo Company plc (NYSE:PRGO) to report earnings on May, 28. They expect $1.23 earnings per share, down 0.81 % or $0.01 from last year’s $1.24 per share. PRGO’s profit will be $173.23 million for 18.66 P/E if the $1.23 EPS becomes a reality. After $1.39 actual earnings per share reported by Perrigo Company plc for the previous quarter, Wall Street now forecasts -11.51 % negative EPS growth.

Perrigo Company plc, together with its subsidiaries, develops, makes, markets, and distributes over-the-counter consumer goods and pharmaceutical products worldwide. The company has market cap of $12.93 billion. It offers OTC products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. It currently has negative earnings. The firm also provides generic and specialty pharmaceutical prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations.

More notable recent Perrigo Company plc (NYSE:PRGO) news were published by: Investorplace.com which released: “Why Charles Schwab Corp (SCHW), Valeant Pharmaceuticals Intl Inc (VRX) and …” on February 28, 2017, also Fool.com with their article: “Why Perrigo Company PLC Ordinary Shares Are Dropping Today” published on April 25, 2016, Streetinsider.com published: “Form 3/A PERRIGO Co plc For: Nov 18 Filed by: Wesolowski John” on December 19, 2017. More interesting news about Perrigo Company plc (NYSE:PRGO) were released by: Fool.com and their article: “Why Perrigo Company plc Stock Is Heading South Today” published on August 10, 2016 as well as Marketwatch.com‘s news article titled: “Perrigo Co. PLC” with publication date: October 29, 2009.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.